Cuvitru

Cuvitru is a subcutaneous immunoglobulin therapy used to treat primary immunodeficiency. This medication helps support the immune system in individuals with weakened defenses.

Cuvitru is primarily used for the treatment of primary immunodeficiency disorders. It works by providing antibodies to help the body fight infections. This therapy is administered subcutaneously, making it a convenient option for patients who require regular immunoglobulin treatment.

Common effects of Cuvitru may include localized reactions at the injection site, such as redness, swelling, or itching. Some individuals may also experience mild systemic reactions like headache or fatigue. These effects are generally temporary and resolve on their own.

Cuvitru should be used under the supervision of a healthcare provider. Patients should be monitored for any signs of allergic reactions or severe side effects. It is important to follow proper handling and storage guidelines to maintain the efficacy of the medication.

Cuvitru may interact with certain medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances should be discussed with a healthcare professional.